Auto Amazon Links: No products found.
Jack Cope, a 30-year-old joiner from Bedford, has lived with hereditary angioedema (HAE)—a condition causing unpredictable and severe swelling—since birth. This illness affects various parts of his body, including his throat, stomach, and face, with even everyday activities like hammering triggering painful swelling in his hands. However, after participating in a clinical trial at Addenbrooke’s Hospital in Cambridge, Jack reports a remarkable improvement in his symptoms. “I was having about an attack a week and I’ve gone from that to nothing for nearly a year now,” he shares, emphasizing how the new treatment has transformed his daily life.
HAE results from a genetic defect affecting the C1 inhibitor protein in the blood, and Jack explains that he tried all existing treatments before opting for the trial. His attacks varied in location and severity, swelling his stomach, lips, hands, and feet at different times. These episodes often required emergency care, leading to frequent visits to A&E where he became well-known to the staff. Jack’s partner, Chloe, took on the role of caregiver during these critical moments. He recalls one frightening night when swelling in his face and throat nearly became life-threatening. “We were able to get to the hospital in time but if I hadn’t woken up, I wouldn’t be here,” he says.
The hereditary nature of HAE means other members of Jack’s family are also affected. He recounts a severe incident involving his grandmother, who suffered swelling of her tongue that led to her heart stopping while unpacking at home. She was successfully revived with a defibrillator and spent time in intensive care on a ventilator. This family history highlights the potentially dangerous consequences of the condition and the importance of effective treatments.
The international trial, supported by the National Institute for Health and Care Research (NIHR) and conducted at Addenbrooke’s Hospital, has encouraged Jack to urge others living with HAE to explore similar opportunities. Since receiving his first infusion last year, he feels empowered to live a more normal life and plans activities without fear. “It’s changed my life,” he states simply. Ruth Hudson, strategic development director at the NIHR Research Delivery Network in the East of England, acknowledges the critical role volunteers like Jack play in advancing research: “Research would be impossible without those like Jack who volunteer, and we owe a debt of gratitude to the many people who took part over the last year.” The final verdict on the success of the trial will follow once the results are formally published
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.